NO932222L - DNA fragmenter som koder for transferrinreseptor subenhetene til Neisseria meningitidis - Google Patents

DNA fragmenter som koder for transferrinreseptor subenhetene til Neisseria meningitidis

Info

Publication number
NO932222L
NO932222L NO932222A NO932222A NO932222L NO 932222 L NO932222 L NO 932222L NO 932222 A NO932222 A NO 932222A NO 932222 A NO932222 A NO 932222A NO 932222 L NO932222 L NO 932222L
Authority
NO
Norway
Prior art keywords
transferrin receptor
dna fragments
neisseria meningitidis
fragments encoding
receptor subunits
Prior art date
Application number
NO932222A
Other languages
English (en)
Norwegian (no)
Other versions
NO932222D0 (no
Inventor
Eric Jacobs
Michele Legrain
Veronique Mazarin
Bernadette Bouchon-Theisen
Anthony B Schryvers
Maire-Aline Bloch
Original Assignee
Pasteur Merieux Serums Vacc
Transgene Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pasteur Merieux Serums Vacc, Transgene Sa filed Critical Pasteur Merieux Serums Vacc
Publication of NO932222D0 publication Critical patent/NO932222D0/no
Publication of NO932222L publication Critical patent/NO932222L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/22—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Neisseriaceae (F)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70582—CD71
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
    • C07K16/1217—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Neisseriaceae (F)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Cell Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
NO932222A 1992-06-19 1993-06-16 DNA fragmenter som koder for transferrinreseptor subenhetene til Neisseria meningitidis NO932222L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9207493A FR2692592B1 (fr) 1992-06-19 1992-06-19 Fragments d'ADN codant pour les sous-unités du récepteur de la transferrine de Neisseria meningitidis et procédés les exprimant.

Publications (2)

Publication Number Publication Date
NO932222D0 NO932222D0 (no) 1993-06-16
NO932222L true NO932222L (no) 1993-12-20

Family

ID=9430946

Family Applications (1)

Application Number Title Priority Date Filing Date
NO932222A NO932222L (no) 1992-06-19 1993-06-16 DNA fragmenter som koder for transferrinreseptor subenhetene til Neisseria meningitidis

Country Status (12)

Country Link
US (2) US6028049A (de)
EP (1) EP0586266B1 (de)
JP (1) JPH06277066A (de)
AT (1) ATE242810T1 (de)
AU (1) AU679911B2 (de)
CA (1) CA2098448A1 (de)
DE (1) DE69333036T2 (de)
ES (1) ES2199938T3 (de)
FI (1) FI932826A (de)
FR (1) FR2692592B1 (de)
HU (1) HU219267B (de)
NO (1) NO932222L (de)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992003467A1 (en) 1990-08-23 1992-03-05 The University Of North Carolina Of Chapel Hill Transferrin binding proteins from neisseria gonorrhoeae and neisseria meningitidis
US5912336A (en) * 1990-08-23 1999-06-15 University Of North Carolina At Chapel Hill Isolated nucleic acid molecules encoding transferrin binding proteins from Neisseria gonorrhoeae and Neisseria meningitidis
FR2692592B1 (fr) * 1992-06-19 1995-03-31 Pasteur Merieux Serums Vacc Fragments d'ADN codant pour les sous-unités du récepteur de la transferrine de Neisseria meningitidis et procédés les exprimant.
CA2173142C (en) * 1993-10-01 2000-11-14 Thomas Bosselmann Method and device for measuring an electrical alternating quantity with temperature compensation
FR2720408B1 (fr) * 1994-05-31 1996-08-14 Pasteur Merieux Serums Vacc Fragments Tbp2 de Neisseria meningitidis.
FR2724936A1 (fr) * 1994-09-22 1996-03-29 Pasteur Merieux Serums Vacc Recepteur lactoferrine d'helicobacter
US6086893A (en) * 1995-10-09 2000-07-11 Pasteur Merieux Serums & Vaccins Helicobacter lactoferrin receptor
FR2739624B1 (fr) * 1995-10-10 1997-12-05 Pasteur Merieux Serums Vacc Nouvelle sous-unite tbp2 de neisseria meningitidis
US6290970B1 (en) * 1995-10-11 2001-09-18 Aventis Pasteur Limited Transferrin receptor protein of Moraxella
US6610506B1 (en) 1995-12-01 2003-08-26 University Technologies International, Inc. Transferrin binding proteins of Pasteurella haemolytica and vaccines containing same
FR2767060B1 (fr) * 1997-08-07 2000-02-11 Pasteur Merieux Serums Vacc Vaccin meningocoque comportant la valence de souche bz83
BR9811907A (pt) * 1997-08-15 2000-08-15 Univ Utrecht Proteìna de ligação de lactoferrina de neisseria
JP5102414B2 (ja) 1998-05-01 2012-12-19 ノバルティス バクシンズ アンド ダイアグノスティックス，インコーポレーテッド 髄膜炎菌抗原および組成物
US10967045B2 (en) 1998-11-02 2021-04-06 Secretary of State for Health and Social Care Multicomponent meningococcal vaccine
US6391316B1 (en) 1999-03-10 2002-05-21 University Of Saskatchewan Vaccine compositions comprising Haemophilus somnus transferrin-binding proteins and methods of use
CN100392082C (zh) * 1999-04-30 2008-06-04 启龙股份公司 保守的奈瑟球菌抗原
DK2270173T3 (en) * 1999-05-19 2016-03-07 Glaxosmithkline Biolog Sa Neisserial combination compositions
AU6490500A (en) * 1999-07-16 2001-02-05 Gerald R. Potts Methods and systems for dynamic force measurement
GB9928196D0 (en) * 1999-11-29 2000-01-26 Chiron Spa Combinations of B, C and other antigens
US6388434B1 (en) 2000-01-17 2002-05-14 Bechtel Bwxt Idaho, Llc Electro-optic high voltage sensor
MXPA02008314A (es) * 2000-02-28 2002-12-09 Chiron Spa Expresion heterologa de proteinas de neisseria.
GB0007433D0 (en) * 2000-03-27 2000-05-17 Microbiological Res Authority Recombinant transferrin binding proteins
US20030232055A1 (en) * 2000-07-31 2003-12-18 Ruslan Medzhitov Innate immune system-directed vaccines
US20030175287A1 (en) * 2001-01-03 2003-09-18 Yale University Innate immune system-directed vaccines
US7138267B1 (en) 2001-04-04 2006-11-21 Epicentre Technologies Corporation Methods and compositions for amplifying DNA clone copy number
GB0121591D0 (en) 2001-09-06 2001-10-24 Chiron Spa Hybrid and tandem expression of neisserial proteins
EP2272946B9 (de) 2002-02-25 2015-06-24 Vaxiion Therapeutics, LLC Minizell-Zusammensetzungen und Verfahren
WO2004015099A2 (en) * 2002-08-02 2004-02-19 Glaxosmithkline Biologicals Sa Vaccine composition comprising lipooligosaccharide with reduced phase variability
GB0220194D0 (en) * 2002-08-30 2002-10-09 Chiron Spa Improved vesicles
CA2501812C (en) 2002-10-11 2012-07-10 Mariagrazia Pizza Polypeptide-vaccines for broad protection against hypervirulent meningococcal lineages
DK2395073T3 (en) 2002-11-01 2017-10-23 Glaxosmithkline Biologicals Sa Process for drying.
RU2378010C2 (ru) 2003-10-02 2010-01-10 Новартис Вэксинес Энд Дайэгностикс С.Р.Л. Жидкие вакцины для множественных серогрупп менингококков
WO2005032584A2 (en) 2003-10-02 2005-04-14 Glaxosmithkline Biologicals S.A. Pertussis antigens and use thereof in vaccination
JP5173194B2 (ja) 2003-12-23 2013-03-27 グラクソスミスクライン バイオロジカルズ ソシエテ アノニム ワクチン
GB0408977D0 (en) 2004-04-22 2004-05-26 Chiron Srl Immunising against meningococcal serogroup Y using proteins
GB0505996D0 (en) 2005-03-23 2005-04-27 Glaxosmithkline Biolog Sa Fermentation process
JP5275983B2 (ja) 2006-06-12 2013-08-28 グラクソスミスクライン バイオロジカルズ ソシエテ アノニム ワクチン
GB0700562D0 (en) 2007-01-11 2007-02-21 Novartis Vaccines & Diagnostic Modified Saccharides
AU2010247252A1 (en) * 2009-05-14 2012-01-12 Sanofi Pasteur Method for admixing the lipopolysaccharide (LPS) of gram-negative bacteria
NZ597007A (en) 2009-05-14 2013-09-27 Sanofi Pasteur Meningococcus vaccine containing lipooligosaccharide (los) from modified strains of l6 immunotype neisseria meningitidis
JP2013521770A (ja) 2010-03-10 2013-06-13 グラクソスミスクライン バイオロジカルズ ソシエテ アノニム ワクチン組成物
CA2810971C (en) 2010-09-10 2020-11-03 Novartis Ag Developments in meningococcal outer membrane vesicles
PT2646470T (pt) 2010-11-30 2017-05-03 Hoffmann La Roche Anticorpos anti-recetor da transferrina de baixa afinidade e a sua utilização na transferência de scfv terapêuticos através da barreira hematoencefálica
WO2013186753A1 (en) 2012-06-14 2013-12-19 Novartis Ag Vaccines for serogroup x meningococcus
JP2016539950A (ja) 2013-12-02 2016-12-22 ビー． シュライバーズ，アンソニー 細菌表面受容体タンパク質由来の免疫原性組成物およびワクチン

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5141743A (en) * 1989-04-27 1992-08-25 University Technologies International, Inc. Method for isolating and purifying transferrin and lactoferrin receptor proteins and vaccines containing the same
US5292869A (en) * 1989-04-27 1994-03-08 The Board Of Governors Of The University Method for isolating and purifying transferrin and lactoferrin receptor proteins from bacteria and the preparation of vaccines containing the same
WO1992003467A1 (en) * 1990-08-23 1992-03-05 The University Of North Carolina Of Chapel Hill Transferrin binding proteins from neisseria gonorrhoeae and neisseria meningitidis
FR2682041B1 (fr) * 1991-10-03 1994-01-14 Pasteur Merieux Serums Vaccins Vaccin contre les infections a neisseria meningitidis.
FR2682114B1 (fr) * 1991-10-03 1996-02-23 Pasteur Merieux Serums Vacc Vaccin de sous-unite contre les infections a neisseria meningitidis et sous-unites correspondantes a l'etat purifie.
FR2692592B1 (fr) * 1992-06-19 1995-03-31 Pasteur Merieux Serums Vacc Fragments d'ADN codant pour les sous-unités du récepteur de la transferrine de Neisseria meningitidis et procédés les exprimant.

Also Published As

Publication number Publication date
US6028049A (en) 2000-02-22
FI932826A (fi) 1993-12-20
FI932826A0 (fi) 1993-06-18
ATE242810T1 (de) 2003-06-15
HU219267B (en) 2001-03-28
FR2692592A1 (fr) 1993-12-24
JPH06277066A (ja) 1994-10-04
AU4009893A (en) 1993-12-23
NO932222D0 (no) 1993-06-16
US6326350B1 (en) 2001-12-04
DE69333036D1 (de) 2003-07-17
EP0586266A1 (de) 1994-03-09
CA2098448A1 (en) 1993-12-20
AU679911B2 (en) 1997-07-17
ES2199938T3 (es) 2004-03-01
DE69333036T2 (de) 2004-05-13
HU9301791D0 (en) 1993-10-28
FR2692592B1 (fr) 1995-03-31
HUT68443A (en) 1995-06-28
EP0586266B1 (de) 2003-06-11

Similar Documents

Publication Publication Date Title
NO932222L (no) DNA fragmenter som koder for transferrinreseptor subenhetene til Neisseria meningitidis
GR3026419T3 (en) Inducing antibody response against self-proteins with the aid of foreign t-cell epitopes
NO20070621L (no) Forbindelser og fremgangsmater for immunterapi og diagnose av tuberkulose
AU3536489A (en) Method for producing recombinant dna proteins
GEP20084431B (en) Papilloma virus vaccine
DK0659276T3 (da) Immunoassay til eftervisning af collagen eller collagenfragmenter
HUP9801714A2 (hu) Neisseria meningitidis TBP2 alegység
HUP9801384A2 (hu) Klostridium perfringens vakcina
FI924222A (fi) Gp75 som ett tumoervaccin mot melanoma
AU8200791A (en) Ehv-4 glycoprotein vaccine
AU4850697A (en) Recombinant adenovirus vaccines
AU2003262810A1 (en) Epha2 antigen t epitopes
DE69626642D1 (de) Cetp zur erhöhung des hdl-cholesterol-gehalts
ATE103983T1 (de) Licht-induzierbarer promotor.